Abstract
Sudden price hikes of decades-old prescription drugs represent a market failure with far-reaching consequences, Sen Susan Collins (R, Maine), chair of the Senate Special Committee on Aging, said at a series of hearings on the subject (http://1.usa.gov/1rezDbf). At the April hearing, retiree Berna Heyman described what happened when Valeant Pharmaceuticals bought the 2 main drugs for treating her Wilson disease, a potentially life-threatening genetic disorder in which the body cannot remove extra copper.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
